Collibra: The Data Governance Layer Life Sciences Needs Before Scaling AI

Overview: How Collibra’s AI-Driven Data Management Platform Transforms Life Sciences Data Governance

Collibra is a data-management platform that helps healthcare and life-sciences organisations catalogue, govern, assess, and share data used in clinical research, drug development, laboratory operations, commercial functions, and AI initiatives. It provides a central layer for defining data assets, assigning ownership, applying policies, tracing lineage, and making governed information easier to discover and reuse across fragmented systems.

The platform addresses a common operational bottleneck: teams often work with disconnected data sources, inconsistent terminology, uncertain provenance, and manual processes for assessing whether information is fit for analysis or reuse. Collibra combines metadata management, data cataloguing, lineage mapping, workflow automation, and machine-learning-supported data-quality and privacy capabilities to identify anomalies, classify sensitive data, and direct remediation activities. This gives organisations a clearer view of data dependencies, transformations, and quality issues before data is used in analytics or AI workflows.

By establishing shared definitions and making trusted datasets more findable, Collibra can reduce time spent locating, interpreting, and validating information across research and operational teams. Its data marketplace and collaboration features are designed to support faster access to reusable data, more consistent analytical decisions, and better cross-functional coordination from early research through clinical and commercial activities.

Last checked on 23 August 2026: Collibra’s latest major platform change is the May 2026 launch of AI Command Center for continuous oversight and control of enterprise AI agents and systems.

What is Collibra?

Collibra is a data-management and AI-governance platform used to catalogue, govern, assess, trace, and share structured and unstructured data across life-sciences and healthcare workflows, including research, clinical trials, laboratory operations, and commercial data use. It is intended for organisations such as hospitals, life-sciences companies, researchers, data teams, and MedTech firms that need shared data definitions, lineage, data-quality controls, controlled access, and reusable data assets. Collibra differentiates itself through ontology-based context governance, machine-learning-supported anomaly detection and sensitive-data classification, and features for audit trails and alignment with requirements such as GxP and IDMP.

Why Do Leading Healthcare Teams Trust Collibra?

• Collibra’s Trust Center lists SOC 1 and SOC 2 attestations and ISO 27001, ISO 27017 cloud-security, ISO 27018 privacy, and ISO 42001 AI-management-system certifications.

• Collibra states that its control framework incorporates NIST, GDPR, CCPA, COSO, and COBIT, and lists HIPAA and FedRAMP among its compliance and assurance programmes.

• Gartner named Collibra a Leader in the 2026 Magic Quadrant for Data and Analytics Governance Platforms for the second consecutive year.

• Forrester named Collibra a Leader in the Q3 2025 Data Governance Solutions Wave and a Strong Performer in the Q3 2025 AI Governance Solutions Wave.

• Collibra holds a Snowflake Partner Network Elite Partner designation and Snowflake competency badges for Healthcare and Life Sciences.

• Collibra was named Databricks’ 2026 Data Governance Partner of the Year, reflecting an active platform partnership relevant to governed lakehouse and AI workloads.

• Collibra acquired Raito in 2025, adding data-access-governance technology to its data and AI governance portfolio.

• Collibra acquired Deasy Labs in 2025, adding automated discovery and enrichment capabilities for unstructured data used in data and AI workflows.